All In Biotech

Free tool

FAERS Monitor: E-Z-Disk

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219840 or its brand name (E-Z-Disk, Barium Sulfate). Reports on generic versions are filed under their own applications.

Reports

259

Serious

194

75% of reports

Hospitalization

116

Death reported

31

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • renal failure18
  • acute kidney injury17
  • urticaria17
  • chronic kidney disease15
  • diarrhoea14
  • rash14
  • dyspnoea13
  • drug hypersensitivity12
  • pruritus12
  • vomiting12
  • abdominal pain10
  • aspiration10
  • fatigue10
  • nausea10
  • pain10

Reports by year received

View as table
YearReports
20052
20063
20073
20088
20094
20108
201112
201212
201317
201413
20159
201618
201723
201818
201916
202011
202118
202220
202316
202410
202512
20266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,900 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
aspirationSignal1074.240.4651
chronic kidney diseaseSignal1516.09.8197
renal failureSignal1811.07.1155
acute kidney injurySignal179.05.7114
urticariaSignal178.25.2102
drug hypersensitivitySignal125.02.935
abdominal painSignal103.51.916
rashSignal142.61.613
pruritusSignal122.51.510
vomitingSignal122.11.26
dyspnoea131.91.15
diarrhoea141.81.14
pain101.30.71
fatigue101.00.60
nausea101.00.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.